Hydrogen peroxide enhances osteopontin expression and matrix metalloproteinase activity in aortic vascular smooth muscle cells

Clinical and Experimental Pharmacology and Physiology

Volumn 36, Issue 7, 2009, Pages 626-630

  Hu, Tao ^a   Luan, Ronghua ^a   Zhang, Haifeng ^a   Lau, Wayne B ^a   Wang, Qiong ^a   Zhang, Yao ^b   Wang, Hai Chang ^a   Tao, Ling ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

Metabolic syndrome; Reactive oxygen species; Restenosis

Indexed keywords

GELATINASE A; HYDROGEN PEROXIDE; MATRIX METALLOPROTEINASE; MESSENGER RNA; OSTEOPONTIN; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CELL CULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; ISCHEMIC HEART DISEASE; NONHUMAN; PERCUTANEOUS CORONARY INTERVENTION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; RESTENOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR TISSUE; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; AORTA; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYDROGEN PEROXIDE; MALE; MATRIX METALLOPROTEINASE 2; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOPONTIN; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 67650711764     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2008.05124.x     Document Type: Article

References (28)

1. Movahed MR. Coronary artery bifurcation lesion classifications, interventional techniques and clinical outcome. Expert Rev. Cardiovasc. Ther. 2008 6 : 261 74.
2. Pashkow FJ, Watumull DG, Campbell CL. Astaxanthin: A novel potential treatment for oxidative stress and inflammation in cardiovascular disease. Am. J. Cardiol. 2008 101 : D58 68.
3. Cai H, Dikalov S, Griendling KK, Harrison DG. Detection of reactive oxygen species and nitric oxide in vascular cells and tissues: Comparison of sensitivity and specificity. Methods Mol. Med. 2007 139 : 293 312.
4. Ranganna K, Mathew OP, Yatsu FM, Yousefipour Z, Hayes BE, Milton SG. Involvement of glutathione/glutathione S-transferase antioxidant system in butyrate-inhibited vascular smooth muscle cell proliferation. FEBS J. 2007 274 : 5962 78.
5. Rudijanto A. The role of vascular smooth muscle cells on the pathogenesis of atherosclerosis. Acta Med. Indones. 2007 39 : 86 93.
6. Leali D, Moroni E, Bussolino F, Presta M. Osteopontin overexpression inhibits in vitro re-endothelialization via integrin engagement. J. Biol. Chem. 2007 282 : 19 676 84.
7. Raffetto JD, Khalil RA. Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. Biochem. Pharmacol. 2008 75 : 346 59.
8. Li JJ, Han M, Wen JK et al. Osteopontin stimulates vascular smooth muscle cell migration by inducing FAK phosphorylation and ILK dephosphorylation. Biochem. Biophys. Res. Commun. 2007 356 : 13 19. (Pubitemid 46413122)
9. Morley ME, Riches K, Peers C, Porter KE. Hypoxic inhibition of human cardiac fibroblast invasion and MMP-2 activation may impair adaptive myocardial remodelling. Biochem. Soc. Trans. 2007 35 : 905 7.
10. Kato R, Momiyama Y, Ohmori R et al. High plasma levels of osteopontin in patients with restenosis after percutaneous coronary intervention. Arterioscler. Thromb. Vasc. Biol. 2006 26 (Suppl E1 2.
11. Liu YN, Pan SL, Peng CY et al. YC-1 [3-(5′-hydroxymethyl-2′- furyl)-1-benzyl indazole] inhibits neointima formation in balloon-injured rat carotid through suppression of expressions and activities of matrix metalloproteinases 2 and 9. J. Pharmacol. Exp. Ther. 2006 316 : 35 41.
12. Ramakrishnan PR, Lin WL, Sodek J, Cao MI. Synthesis of noncollagenous extracellular matrix proteins during development of mineralized nodules by rat periodontal ligament cells in vitro. Calcif. Tissue Int. 1995 57 : 52 9.
13. Zhou XX, Wen JK, Han M et al. Effect of IL-1β and TNF-α on osteopontin expression and matrix metalloproteinase activity of vascular smooth muscle cells. Chin. J. Arterioscler. 1999 7 : 292 5 (in Chinese with an English abstract).
14. Rharass T, Vigo J, Salmon JM, Ribou AC. New method for the detection of reactive oxygen species in anti-tumoural activity of adriamycin: A comparison between hypoxic and normoxic cells. Free Radic. Res. 2008 42 : 124 34.
15. Bian K, Doursout MF, Murad F. Vascular system: Role of nitric oxide in cardiovascular diseases. J. Clin. Hypertens. 2008 10 : 304 10.
16. Zargham R. Preventing restenosis after angioplasty: A multistage approach. Clin. Sci. 2008 114 : 257 64.
17. Roztocil E, Nicholl SM, Davies MG. Sphingosine-1-phosphate-induced oxygen free radical generation in smooth muscle cell migration requires Gα12/13 protein-mediated phospholipase C activation. J. Vasc. Surg. 2007 46 : 1253 9.
18. Haylock DN, Nilsson SK. Osteopontin. A bridge between bone and blood. Br. J. Haematol. 2006 134 : 467 74.
19. Giachelli C, Bae N, Lombardi D. Molecular cloning and characterization of 2B7, a rat mRNA which distinguishes smooth muscle cell phenotypes in vitro and is identical to osteopontin (secreted phosphoprotein I, 2aR). Biochem. Biophys. Res. Commun. 1991 177 : 867 73.
20. Scatena M, Liaw L, Giachelli CM. Osteopontin: A multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 2007 27 : 2302 9.
21. Saitoh E, Nagae Y, Wachi H et al. Variance of expressions of extracellular matrix components and effects of anti-osteoporotic drugs on Mönckeberg's arteriosclerosis. Yakugaku Zasshi 2008 128 : 385 92 (in Japanese with an English abstract).
22. Isoda K, Nishikawa K, Kamezawa Y et al. Osteopontin plays an important role in the development of medial thickening and neointimal formation. Circ. Res. 2002 91 : 77 82. (Pubitemid 34778945)
23. Chaulet H, Desgranges C, Renault MA et al. Extracellular nucleotides induce arterial smooth muscle cell migration via osteopontin. Circ. Res. 2001 89 : 772 8.
24. Han M, Wen JK, Zheng B, Liu Z, Chen Y. Blockade of integrin beta3-FAK signaling pathway activated by osteopontin inhibits neointimal formation after balloon injury. Cardiovasc. Pathol. 2007 16 : 283 90.
25. Jalvy S, Renault MA, Lam Shang Leen L et al. CREB mediates UTP-directed arterial smooth muscle cell migration and expression of the chemotactic protein osteopontin via its interaction with activator protein-1 sites. Circ. Res. 2007 100 : 1292 9.
26. Delbosc S, Glorian M, Le Port AS et al. The benefit of docosahexanoic acid on the migration of vascular smooth muscle cells is partially dependent on Notch regulation of MMP-2/-9. Am. J. Pathol. 2008 172 : 1430 40.
27. Ambalavanan N, Nicola T, Li P et al. Role of matrix metalloproteinase-2 in newborn mouse lungs under hypoxic conditions. Pediatr. Res. 2008 63 : 26 32.
28. Solomatina MA, Plekhanova OS, Men'shikova MY, Ratner EI, Tkachuk VA, Parfenova EV. Urokinase increases the content and activity of matrix metalloproteinases 2 and 9 during in vivo constrictive arterial remodeling. Bull. Exp. Biol. Med. 2005 139 : 283 6.